Marc-Oliver Grimm

20PUBLICATIONS
51CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical physicsLiquid biopsiesGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jul 15, 2026
Real-World Data on the Use of Nivolumab Monotherapy in the Treatment of Advanced Renal Cell Carcinoma After Prior Therapy: Final Results from the Non-Interventional NORA Study.

|May 19, 2026
Differential effects of prior versus concomitant Steroid and Antibiotic Treatment on Immunotherapy Efficacy - A Pooled Analysis of the RAMONA, INTEGA, OPTIM, ELDORANDO, FORCE, TITAN-RCC and TITAN-TCC Trials of the German AIO Study Group.

|Dec 30, 2025
Prostate Artery Embolization vs. Holmium Laser Enucleation of the Prostate: A Matched Pair Analysis of Functional Outcomes and Complications.

Simon Hannes Friedrich Leschik, Robert Große Siemer, Friedrich-Carl von Rundstedt

|Nov 14, 2025
Two-Stage Estimation of Overall Survival in the Phase 3 CheckMate 9ER Trial, Adjusting for the Impact of Subsequent Therapy.

Marc-Oliver Grimm, Emma Karim, Venediktos Kapetanakis

|Oct 26, 2024
Complications of Tumor Nephrectomy with and Without Tumor Thrombus in the Vena Cava, Recorded with the Clavien-Dindo Classification: A Matched-Pair Analysis.

Ute Maria Frölich, Katharina Leucht, Marc-Oliver Grimm

|Sep 20, 2024
Adjuvant Nivolumab for Localized Renal Cell Carcinoma at High Risk of Recurrence After Nephrectomy: Part B of the Randomized, Placebo-Controlled, Phase III CheckMate 914 Trial.

Robert J Motzer, Axel Bex, Paul Russo

Pageof 4

Frequent Collaborators

5 joint publications

Katharina Leucht

4 joint publications

Daniel Steinbach

3 joint publications

Roland Kotolloshi

3 joint publications

Viktor Grünwald